ROIS
ROIS is a leading global CDMO with locations in US and EU specializing in sterile injectable fill-finish, with a sterile fill capacity of approximately 800 million units annually in vials, prefilled syringes, and cartridges. ROIS provides dedicated cytotoxic and high-potent (OEB5) manufacturing capabilities in the U.S., including segregated fill-finish and lyophilization suites for antibody-drug conjugates (ADCs) and other complex oncology products.
